BFM

Boothbay Fund Management Portfolio holdings

AUM $3.28B
1-Year Return 35.55%
This Quarter Return
+4.07%
1 Year Return
+35.55%
3 Year Return
+95.77%
5 Year Return
+153.31%
10 Year Return
+435.74%
AUM
$870M
AUM Growth
+$109M
Cap. Flow
+$95.9M
Cap. Flow %
11.02%
Top 10 Hldgs %
23.11%
Holding
939
New
238
Increased
169
Reduced
128
Closed
261

Sector Composition

1 Technology 13.42%
2 Healthcare 10.43%
3 Communication Services 9.92%
4 Financials 8.33%
5 Real Estate 5.4%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CENT icon
851
Central Garden & Pet
CENT
$2.37B
-10,170
Closed -$208K
CHKP icon
852
Check Point Software Technologies
CHKP
$20.7B
0
CL icon
853
Colgate-Palmolive
CL
$68.8B
-4,104
Closed -$281K
CLSD icon
854
Clearside Biomedical
CLSD
$27.2M
-390,000
Closed -$538K
CMA icon
855
Comerica
CMA
$8.85B
-3,003
Closed -$220K
COLL icon
856
Collegium Pharmaceutical
COLL
$1.21B
-52,804
Closed -$799K
COP icon
857
ConocoPhillips
COP
$116B
-4,690
Closed -$313K
CPB icon
858
Campbell Soup
CPB
$10.1B
-15,634
Closed -$596K
CRK icon
859
Comstock Resources
CRK
$4.66B
-22,386
Closed -$155K
CROX icon
860
Crocs
CROX
$4.72B
-25,130
Closed -$647K
CSTM icon
861
Constellium
CSTM
$2.04B
-20,000
Closed -$160K
CTSH icon
862
Cognizant
CTSH
$35.1B
0
CVX icon
863
Chevron
CVX
$310B
-2,342
Closed -$288K
CWEN icon
864
Clearway Energy Class C
CWEN
$3.38B
-22,490
Closed -$340K
DARE icon
865
Dare Bioscience
DARE
$29M
-1,528
Closed -$26K
DBEM icon
866
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$71.3M
0
DD icon
867
DuPont de Nemours
DD
$32.6B
-8,277
Closed -$890K
DSU icon
868
BlackRock Debt Strategies Fund
DSU
$547M
-75,000
Closed -$804K
EAD
869
Allspring Income Opportunities Fund
EAD
$421M
-18,480
Closed -$146K
EOLS icon
870
Evolus
EOLS
$495M
0
ESPR icon
871
Esperion Therapeutics
ESPR
$540M
0
EVOK icon
872
Evoke Pharma
EVOK
$8.12M
-107
Closed -$23K
EXPE icon
873
Expedia Group
EXPE
$26.6B
-4,203
Closed -$500K
EYPT icon
874
EyePoint Pharmaceuticals
EYPT
$966M
-3,042
Closed -$54K
FATE icon
875
Fate Therapeutics
FATE
$116M
-36,800
Closed -$647K